Jan 12, 2022 / 02:00PM GMT
Tycho W. Peterson - JPMorgan Chase & Co, Research Division - Senior Analyst
Good morning, everybody. Welcome to Day 3 of the Healthcare Conference. I'm Tycho Peterson from the (inaudible) team. It's my pleasure to introduce our next company this morning, Quest Diagnostics. Just a quick reminder, if you have questions, you can submit them through the website.
And with that, let me turn it over to Steve.
Stephen H. Rusckowski - Quest Diagnostics Incorporated - Chairman, President & CEO
Thanks, Tycho. Good morning, everyone, and thanks for joining us for our introductory presentation and be happy to be taking any questions during our Q&A. So as you see here in the title slide, we are poised for growth in our post-pandemic world and what we'd like to talk you through is what we see happening in our market and what we see happening with our company and what we see for our opportunities for growth going forward.
Next slide, please. Safe harbor statement and disclosure of that.
So what you're going to hear from us today is,
Quest Diagnostics Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 12, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers